These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32396465)

  • 1. Possible roles of epigenetics in stem cell therapy for Parkinson's disease.
    Thompson C; Otero P; Srinageshwar B; Petersen RB; Dunbar GL; Rossignol J
    Epigenomics; 2020 Apr; 12(7):647-656. PubMed ID: 32396465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting epigenetic modifications in Parkinson's disease therapy.
    Zhang D; Zhang J; Wang Y; Wang G; Tang P; Liu Y; Zhang Y; Ouyang L
    Med Res Rev; 2023 Sep; 43(5):1748-1777. PubMed ID: 37119043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview of Epigenetic Changes in the Parkinson's Disease Brain.
    Klokkaris A; Migdalska-Richards A
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic-based therapies.
    Renani PG; Taheri F; Rostami D; Farahani N; Abdolkarimi H; Abdollahi E; Taghizadeh E; Gheibi Hayat SM
    J Cell Physiol; 2019 Nov; 234(11):19307-19319. PubMed ID: 30968426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic mechanisms in Parkinson's disease.
    Feng Y; Jankovic J; Wu YC
    J Neurol Sci; 2015 Feb; 349(1-2):3-9. PubMed ID: 25553963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities.
    Ammal Kaidery N; Tarannum S; Thomas B
    Neurotherapeutics; 2013 Oct; 10(4):698-708. PubMed ID: 24030213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation in Parkinson's disease.
    Labbé C; Lorenzo-Betancor O; Ross OA
    Acta Neuropathol; 2016 Oct; 132(4):515-30. PubMed ID: 27358065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Modulation in Parkinson's Disease and Potential Treatment Therapies.
    Rathore AS; Birla H; Singh SS; Zahra W; Dilnashin H; Singh R; Keshri PK; Singh SP
    Neurochem Res; 2021 Jul; 46(7):1618-1626. PubMed ID: 33900517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson's Disease Mouse Model.
    Park H; Chang KA
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson's disease patients.
    Fernández-Santiago R; Merkel A; Castellano G; Heath S; Raya Á; Tolosa E; Martí MJ; Consiglio A; Ezquerra M
    Clin Epigenetics; 2019 Jul; 11(1):108. PubMed ID: 31337434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the Expression and Epigenetics of Genes Involved in Monogenic Forms of Parkinson's Disease Influence Sporadic Forms?
    Lanore A; Lesage S; Mariani LL; Menon PJ; Ravassard P; Cheval H; Corti O; Brice A; Corvol JC
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancements in Autologous Stem Cell Transplantation for Parkinson's Disease.
    Shi JX; Zhang KZ
    Curr Stem Cell Res Ther; 2024; 19(10):1321-1327. PubMed ID: 37691194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation in Parkinson's disease.
    Wüllner U; Kaut O; deBoni L; Piston D; Schmitt I
    J Neurochem; 2016 Oct; 139 Suppl 1():108-120. PubMed ID: 27120258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemispheric asymmetry in the human brain and in Parkinson's disease is linked to divergent epigenetic patterns in neurons.
    Li P; Ensink E; Lang S; Marshall L; Schilthuis M; Lamp J; Vega I; Labrie V
    Genome Biol; 2020 Mar; 21(1):61. PubMed ID: 32151270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.
    Jakubowski JL; Labrie V
    J Parkinsons Dis; 2017; 7(1):1-12. PubMed ID: 27792016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin C-Induced Epigenetic Modifications in Donor NSCs Establish Midbrain Marker Expressions Critical for Cell-Based Therapy in Parkinson's Disease.
    Wulansari N; Kim EH; Sulistio YA; Rhee YH; Song JJ; Lee SH
    Stem Cell Reports; 2017 Oct; 9(4):1192-1206. PubMed ID: 28943252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics.
    Uppala SN; Tryphena KP; Naren P; Srivastava S; Singh SB; Khatri DK
    Mech Ageing Dev; 2023 Jul; 213():111826. PubMed ID: 37268278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.